)

Champions Oncology (CSBR) investor relations material
Champions Oncology Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Achieved $14.0 million in Q1 revenue, showing sequential growth but a slight year-over-year decline, with stability in core oncology and technology-enabled research services.
Growth was led by the TOS business and increasing contributions from the data platform, with ongoing expansion in radiopharmaceutical services and the Corellia drug discovery subsidiary.
Leadership transition with a new CEO, Rob Brainin, emphasizing continuity, strategic execution, and long-term growth.
Focus on expanding data-driven platforms, SaaS, and proprietary dataset licensing, with a robust pipeline at various discovery and validation stages.
Ongoing evaluation of strategic options for value creation and external funding for subsidiaries.
Financial highlights
Q1 revenue was $14.0 million, flat year-over-year but up from $12.4 million in Q4, with research services contributing $13.7 million and data business providing the remainder.
GAAP operating loss of $0.5 million and net loss attributable to common shares of $436,000, or $(0.03) per share, compared to net income of $1.3 million, or $0.10 per share, last year.
Adjusted EBITDA was $60,000, down from $2.0 million in the prior year.
Gross margin declined to 43% from 50% year-over-year due to higher outsourced lab costs.
Ended Q1 with $10.3 million in cash, up $0.5 million from year-end, and remained debt-free.
Outlook and guidance
Management anticipates sequential revenue growth and margin expansion as radiolabeling work shifts in-house and demand for proprietary data offerings increases.
Expects cash neutrality in Q2 and cash growth in the second half of fiscal 2026, with liquidity sufficient through at least October 2026.
Ongoing focus on expanding data licensing, SaaS, and R&D investment, with cautious optimism about improving market conditions.
Next Champions Oncology earnings date

Next Champions Oncology earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage